phase readout
saveNCT02609776: Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Non-Small-Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that